Uncategorized
Astellas Brings 21 Abstracts to ESMO 2026, Results Still Under Wraps
Astellas Pharma Inc. (Tokyo Stock Exchange: 4503) will bring 21 abstracts to the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, running October 23 to 27, the company said in a press release issued October 6. Titles, presenters and time slots are all there. Results are not. The release does not contain a…
